Benzimidazole

Benzimidazole

SCHEMBL7413340

Cc1c(Cl)ccc2nc(Cl)[nH]c12.c1ccc2[nH]cnc2c1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
RAB9A P51151 4/20 0.35
KDM4E B2RXH2 4/20 0.35
NPC1 O15118 3/20 0.35
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
TP53 P04637 1/20 0.35
ATP4A P20648 1/20 0.35
ATP4B P51164 1/20 0.35
QPCTL Q9NXS2 2/20 0.34
CASP6 P55212 1/20 0.33
MMP12 P39900 1/20 0.33
QPCT Q16769 3/20 0.33
HTT P42858 2/20 0.33
PARP1 P09874 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PRKCI P41743 1/20 0.33
MAPT P10636 1/20 0.32
RAD52 P43351 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzimidazole SCHEMBL7413336 0.82 NPC1 (0.42) ALDH1A1RAB9AKDM4ENPC1HPGD
SCHEMBL659974 0.81 MAPT (0.40) ALDH1A1ATP4AATP4BPARP1MAPT
Benzimidazole SCHEMBL28467044 0.73 SMN1; SMN2 (0.45) ALDH1A1RAB9AKDM4ENPC1HPGD
Benzimidazole SCHEMBL376958 0.73 MMP12 (0.46) ALDH1A1RAB9AKDM4ENPC1HPGD
SCHEMBL7348969 0.71 PARP1 (0.37) ALDH1A1RAB9AKDM4ENPC1SMN1; SMN2
Benzimidazole SCHEMBL29218507 0.71 MMP12 (0.47) ALDH1A1RAB9AKDM4ENPC1HPGD
Benzimidazole SCHEMBL461969 0.71 SMN1; SMN2 (0.50) ALDH1A1RAB9AKDM4ENPC1HPGD
Benzimidazole SCHEMBL6009 0.71
Benzimidazole SCHEMBL10931770 0.71 SMN1; SMN2 (0.50) ALDH1A1RAB9AKDM4ENPC1HPGD
Benzimidazole SCHEMBL29408372 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed